The Impact of Wearable Devices on Clinical Trials

posted on November 5th 2015 in Data Talk with 0 Comments /

From Google X revealing a smartwatch designed for clinical trial use to the growing number Apple ResearchKit based trials, mobile technology and wearable devices are popular topics of discussion among life science professionals. There’s a prevailing idea that the technology people use every day can be utilized to provide real-world data for researchers and make it easier and more appealing for people to provide this clinical data.

When should you use wearable devices?

While there are many clinical applications for current wearableWomen Using Wearable Device devices, some think these commercial-grade devices simply aren’t capable of providing the appropriate levels of information security and data integrity. While these arguments are valid, it won’t take long for the likes of Apple and Google to leverage their technology and marketing power to impact healthcare and the way clinical trials are conducted.

Using wearable devices in a clinical trial may sound non-traditional to some, but for those that are excited to get a jump-start on the future – there are many questions you must ask before you should utilize a wearable technology.

  • Will a wearable device help you answer your research question(s)?
  • Do you require a sensor that is readily available on consumer devices or will you need a medical grade device?
  • How will you receive the data from the device?
  • Will you be able to analyze the data once you have it?

These are the questions you need to answer before committing to using a wearable device in your clinical trial. Depending on the study, there may be even more questions! Just like anything in clinical development, your decisions must be strategic and well thought out.

Advanced technology in the near future.

With consumers gaining access to more and more biosensors, advanced cloud technology and improved Nano technology, the way we conduct clinical research in the life sciences industry will dramatically change. Lower development costs, improved patient recruitment and monitoring and ultimately lower therapy costs will improve the industry as a whole. It’s not a matter of “if”, but a matter of when this technology will take off.

about the author: ecs

Please let us know your thoughts...